Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-019763)

Filing Details

Accession Number:: 0000899243-21-019763
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-18 16:45:22
Reporting Period:: 2021-05-14

Accepted Time:: 2021-05-18 16:45:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1816736	Gemini Therapeutics Inc.	GMTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1815308	Brian Piekos	C/O Gemini Therapeutics, Inc. 300 One Kendall Square, 3Rd Floor Cambridge MA 02139	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-14	7,655	$9.46	7,655	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.30 to $9.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.